IL6 and major depressive disorder: To carry out a proof-of-concept, randomised, parallel-group, double-blind, placebo-controlled clinical trial to test whether IL-6 contributes to pathogenesis of depression and to examine potential mechanisms by which IL-6 affects mood and cognition.